VESIcare (Astellas Pharma US, Inc.)
Welcome to the PulseAid listing for the VESIcare drug offered from Astellas Pharma US, Inc.. This Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Astellas Pharma US, Inc. |
| NON-PROPRIETARY NAME: | solifenacin succinate |
| SUBSTANCE NAME: | SOLIFENACIN SUCCINATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2005-01-05 |
| END MARKETING DATE: | 0000-00-00 |
VESIcare HUMAN PRESCRIPTION DRUG Details:
| Item Description | VESIcare from Astellas Pharma US, Inc. |
| LABELER NAME: | Astellas Pharma US, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2005-01-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51248-150_8b3031ca-3676-499a-ac82-53fc20116aa5 |
| PRODUCT NDC: | 51248-150 |
| APPLICATION NUMBER: | NDA021518 |
Other SOLIFENACIN SUCCINATE Pharmaceutical Manufacturers / Labelers:
